Difficulty: Medium
Average Score: 83%
Practice
The client is diabetic and is given a non-cardio-selective beta blocker. What might happen to the blood sugars?
Correct answer
B
Rationale
Correct Answer: B - The blood sugar drops due to impaired production of glucose from glycogen.
Rationale:
1. Non-cardio-selective beta blockers inhibit beta-2 receptors in the liver.
2. Beta-2 receptors stimulate glycogenolysis, converting glycogen to glucose.
3. Inhibition of glycogenolysis leads to impaired production of glucose from glycogen.
4. Consequently, blood sugar levels decrease due to reduced availability of glucose.
Summary of Other Choices:
A: Incorrect. Non-cardio-selective beta blockers inhibit glycogenolysis, leading to decreased breakdown of glycogen and reduced glucose production, resulting in lower blood sugar levels.
C: Incorrect. Non-cardio-selective beta blockers do affect blood sugar by impairing glucose production from glycogen.
D: Incorrect. Non-cardio-selective beta blockers do not increase cellular uptake of glucose, but rather decrease glucose production from glycogen.
Rationale:
1. Non-cardio-selective beta blockers inhibit beta-2 receptors in the liver.
2. Beta-2 receptors stimulate glycogenolysis, converting glycogen to glucose.
3. Inhibition of glycogenolysis leads to impaired production of glucose from glycogen.
4. Consequently, blood sugar levels decrease due to reduced availability of glucose.
Summary of Other Choices:
A: Incorrect. Non-cardio-selective beta blockers inhibit glycogenolysis, leading to decreased breakdown of glycogen and reduced glucose production, resulting in lower blood sugar levels.
C: Incorrect. Non-cardio-selective beta blockers do affect blood sugar by impairing glucose production from glycogen.
D: Incorrect. Non-cardio-selective beta blockers do not increase cellular uptake of glucose, but rather decrease glucose production from glycogen.